Abstract
This chapter reviews the clinical, macroscopic, and microscopic features, as well as the differential diagnosis of the most common lesions and tumors of the urinary bladder. Applicable ancillary testing modalities including immunohistochemistry and molecular findings are discussed. Several summary tables and photomicrographs are included to facilitate the use of this chapter as a quick reference guide for routine surgical pathology practice.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSUGGESTED READING
Abbosh PH, Wang M, Eble JN, Lopez-Beltran A, Maclennan GT, Montironi R, Zheng S, Pan CX, Zhou H, Cheng L. Hypermethylation of tumor-suppressor gene CpG islands in small-cell carcinoma of the urinary bladder. Mod Pathol 2008;21:355–362.
Amin MB, Gomez JA, Young RH. Urothelial transitional cell carcinoma with endophytic growth patterns: a discussion of patterns of invasion and problems associated with assessment of invasion in 18 cases. Am J Surg Pathol 1997;21:1057–1068.
Amin MB, Young RH. Intraepithelial lesions of the urinary bladder with a discussion of the histogenesis of urothelial neoplasms. Semin Diagn Pathol 1997;14:84–97.
Amin MB. Histological variants of urothelial carcinoma: diagnostic, therapeutic and prognostic implications. Mod Pathol 2009;22 (S2):S96–S118.
Armstrong AB, Wang M, Eble JN, MacLennan GT, Montironi R, Tan PH, Lopez-Beltran A, Zhang S, Baldridge LA, Spartz H, Cheng L. TP53 mutational analysis supports monoclonal origin of biphasic sarcomatoid urothelial carcinoma (carcinosarcoma) of the urinary bladder. Mod Pathol 2009;22:113–118.
Barbisan F, Santinelli A, Mazzucchelli R, Lopez-Beltran A, Cheng L, Scarpelli M, van der Kwast T, Montironi R. Strong immunohistochemical expression of fibroblast growth factor receptor 3, superficial staining pattern of cytokeratin 20, and low proliferative activity define those papillary urothelial neoplasms of low malignant potential that do not recur. Cancer 2008;112:636–644.
Bol MG, Baak JP, Buhr-Wildhagen S, et al. Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder. J Urol 2003;169:1291–1294.
Bostwick DG, Mikuz G. Urothelial papillary (exophytic) neoplasms. Virchows Arch 2002;441:109–116.
Bostwick DG, Ramnani DM, Cheng L. Diagnosis and grading of bladder cancer and associated lesions. Urol Clin North Am 1999;26:493–508.
Bostwick DG. Natural history of early bladder cancer. J Cell Biochem (Suppl) 1992;16I:31–38.
Chan TY, Epstein JI. Radiation or chemotherapy cystitis with “pseudocarcinomatous” features. Am J Surg Pathol 2004;28:909–913.
Cheng L, Zhang S, Davidson DD, MacLennan GT, Koch MO, Montironi R, Lopez-Beltran A. Molecular determinants of tumor recurrence in the urinary bladder. Future Oncol 2009;5:843–857.
Cheng L, Montironi R, Davidson DD, Lopez-Beltran A. Staging and reporting of urothelial carcinoma of the urinary bladder. Mod Pathol 2009;22 (S2):S70–S95.
Cheng L, Jones TD, McCarthy RP, Eble JN, Wang M, MacLennan GT, Lopez-Beltran A, Yang XJ, Koch MO, Zhang Z, Pan CX, Baldridge LA. Molecular genetic evidence for a common clonal origin of urinary bladder small cell carcinoma and co-existing urothelial carcinoma. Am J Pathol 2005;166:1533–1539.
Cheng L, Foster SR, MacLennan GT, Lopez-Beltran A, Zhang S, Montironi R. Inflammatory myofibroblastic tumors of the genitourinary tract – single entity or continuum? J Urol 2008;180:1235–1240.
Cheng L, Neumann RM, Nehra A, et al. Cancer heterogeneity and its biologic implications in the grading of urothelial carcinoma. Cancer 2000;88:1663–1670.
Cheng L, Neumann RM, Weaver AL, et al. Predicting cancer progression in patients with stage T1 bladder carcinoma. J Clin Oncol 1999;17: 3182–3187.
Cheng L, Pan CX, Yang XJ, et al. Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients. Cancer 2004;101:957–962.
Cheng L, Weaver AL, Leibovich BC, et al. Predicting the survival of bladder carcinoma patients treated by radical cystectomy. Cancer 2000;88:2326–2332.
Cheng L, Bostwick DG. Overdiagnosis of bladder carcinoma. Anal Quant Cytol Histol 2008;30:261–264.
Cheng L, Cheville JC, Leibovich BC, et al. Survival of patients with carcinoma in situ of the urinary bladder. Cancer 1999;85:2469–2474.
Cheng L, Cheville JC, Neumann RM, et al. Flat intraepithelial lesions of the urinary bladder. Cancer 2000;88:625–631.
Cheng L, Cheville JC, Roxann N, et al. Natural history of urothelial dysplasia of the bladder. Am J Surg Pathol 1999;23:443–447.
Cheng L, Cheville JC, Sebo TJ, et al. Atypical nephrogenic metaplasia of the urinary tract: a precursor lesion? Cancer 2000;88:853–861.
Cheng L, Darson M, Cheville JC. Urothelial papilloma of the bladder: clinical and biological implications. Cancer 1999;86:2098–2101.
Cheng L, Gu J, Ulbright TM, et al. Precise microdissection of human bladder cancers reveals divergent tumor subclones in the same tumor. Cancer 2002;94:104–110.
Cheng L, Leibovich BC, Ramnani DM. Pheochromocytoma of the urinary bladder: can biologic potential be predicted? Cancer 2000;88:844–852.
Cheng L, MacLennan GT, Pan CX, et al. Allelic loss of the active X chromosome during bladder carcinogenesis. Arch Pathol Lab Med 2004;128:187–190.
Cheng L, MacLennan GT, Zhang S, et al. Laser capture microdissection analysis reveals frequent allelic losses in papillary urothelial neoplasm of low malignant potential of the urinary bladder. Cancer 2004;101: 183–188.
Cheng L, Montironi R, Bostwick DG. Villous adenoma of the urinary tract: a report of 23 cases including 8 with coexistent adenocarcinoma. Am J Surg Pathol 1999;23:764–771.
Cheng L, Bostwick DG, Li G, et al. Conserved genetic findings in metastatic bladder cancer: a possible utility of allelic loss of chromosome 9p21 and 17p13 in diagnosis. Arch Pathol Lab Med 2001;125:1197–1199.
Cheng L, Nascimento AG, Neuman RM, et al. Hemangioma of the urinary bladder. Cancer 1999;86:498–504.
Cheng L, Neumann RM, Scherer BG, et al. Tumor size predicts the survival of patients with pathologic stage T2 bladder carcinoma: a critical evaluation of the depth of muscle invasion. Cancer 1999;85:2638–2647.
Cheng L, Neumann RM, Bostwick DG. Papillary urothelial neoplasm of low malignant potential: clinical and biological implications. Cancer 1999;86:2102–2108.
Cheng L, Neumann RM, Weaver AL, et al. Grading and staging of bladder carcinoma in the transurethral resection specimens. Am J Clin Pathol 2000;113:275–279.
Cheng L, Scheithauer BW, Leibovich BC, et al. Neurofibroma of the urinary bladder. Cancer 1999;86:505–513.
Cheng L, Weaver AL, Bostwick DG. Predicting extravesical extension of bladder carcinoma. Urology 2000;55:668–672.
Cheng L, Weaver AL, Neumann RM, et al. Substaging of T1 bladder carcinoma based on the depth of invasion as measured by micrometer: a new proposal. Cancer 1999;86:1035–1043.
Cheng L, Davidson DD, MacLennan GT, Williamson SR, Zhang S, Koch MO, Montironi R, Lopez-Beltran A. The Origins of Urothelial Carcinoma. Exp Rev Anticancer Ther 2010;10:865–880.
Clement PB, Young RH. Endocervicosis of the urinary bladder: a report of six cases of a benign mullerian lesion that may mimic adenocarcinoma. Am J Surg Pathol 1992;16:533–542.
Eble JN, Young RH. Carcinoma of the urinary bladder: a review of its diverse morphology. Semin Diagn Pathol 1997;14:98–108.
Epstein JI, Amin MB, Reuter VR, et al. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 1998;22:1435–1448.
Freeman A, Geddes N, Munson P, et al. Anaplastic lymphoma kinase (ALK 1) staining and molecular analysis in inflammatory myofibroblastic tumours of the bladder: a preliminary clinicopathological study of nine cases and review of the literature. Mod Pathol 2004;17:765–771.
Grignon DJ, Ro JY, Ayala AG, et al. Primary adenocarcinoma of the urinary bladder: a clinicopathologic analysis of 72 cases. Cancer 1991;67:2165–2172.
Grignon DJ, Ro JY, Ayala AG, et al. Primary signet-ring cell carcinoma of the urinary bladder. Am J Clin Pathol 1991;95:13–20.
Grignon DJ. The current classification of urothelial neoplasms. Mod Pathol 2009;22 (S2):S60–S69.
Guo CC, Fine SW, Epstein JI. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases. Am J Surg Pathol 2006;30:883–891.
Gupta A, Wang HL, Policarpio-Nicolas ML, et al. Expression of alpha-methylacyl-coenzyme a racemase in nephrogenic adenoma. Am J Surg Pathol 2004;28:1224–1229.
Harnden P, Mahmond N, Southgate J. Expression of cytokeratin 20 defines urothelial papillomas of the bladder. Lancet 1999;353:974–977.
Hansel DE, Nadasdy T, Epstein JI. Fibromyxoid nephrogenic adenoma: a newly recognized variant mimicking mucinous adenocarcinoma. Am J Surg Pathol 2007;31:1231–1237.
Hodges KB, Lopez-Beltran A, Davidson DD, Montironi R, Cheng L. Urothelial dysplasia and other flat lesions of the urinary bladder: clinicopathological and molecular features. Hum Pathol 2010;41:155–162.
Iczkowski KA, Shanks JH, Gadaleana V, et al. Inflammatory pseudotumor and sarcoma of urinary bladder: differential diagnosis and outcome in 38 spindle cell neoplasms. Mod Pathol 2001;14:1043–1051.
Jiang J, Ulbright TM, Younger C, et al. Cytokeratin 7 and cytokeratin 20 in primary urinary bladder carcinoma and matched lymph node metastasis. Arch Pathol Lab Med 2001;125:921–923.
Jimenez RE, Gheiler E, Oskanian P, et al. Grading the invasive component of urothelial carcinoma of the bladder and its relationship with progression-free survival. Am J Surg Pathol 2000;24:980–987.
Jone EC, Clement PB, Young RH. Inflammatory pseudotumor of the urinary bladder. Am J Surg Pathol 1993;17:264–274.
Jones TD, Carr MD, Eble JN, Wang M, Lopez-Beltran A, Cheng L. Clonal origin of lymph node metastases in bladder carcinoma. Cancer 2005;104:1901–1910.
Jones TD, Kernek KM, Yang XJ, Lopez-Beltran A, MacLennan GT, Eble JN, Lin H, Pan CX, Tretiakova M, Baldridge LA, Cheng L. Thyroid transcription factor 1 expression in small cell carcinoma of the urinary bladder: an immunohistochemical profile of 44 cases. Hum Pathol 2005;36:718–723.
Jones TD, Wang M, Eble JN, MacLennan GT, Lopez-Beltran A, Zhang S, Cocco A, Cheng L. Molecular evidence supporting field effect in urothelial carcinogenesis. Clin Cancer Res 2005;11:6512–6519.
Jones TD, Zhang S, Lopez-Beltran A, Eble JN, Sung MT, MacLennan GT, Montironi R, Tan PH, Zheng S, Baldridge LA, Cheng L. Urothelial carcinoma with an inverted growth pattern can be distinguished from inverted papilloma by fluorescence in situ hybridization, immunohistochemistry, and morphologic analysis. Am J Surg Pathol 2007;31:1861–1867.
Lacy S, Lopez-Beltran A, MacLennan GT, Foster SR, Montironi R, Cheng L. Molecular pathogenesis of urothelial carcinoma: the clinical utility of emerging new biomarkers and future molecular classification of bladder cancer. Anal Quant Cytol Histol 2009;31:5–16.
Lagwinski N, Thomas A, Stephenson AJ, Campbell S, Hoschar AP, El-Gabry E, Dreicer R, Hansel DE. Squamous cell carcinoma of the bladder: a clinicopathologic analysis of 45 cases. Am J Surg Pathol 2007; 31:1777–1787.
Lopez Beltran A, Bassi P, Pavone-Macaluso M, et al. Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ureter, and renal pelvis. Eur Urol 2004;45:257–266.
Lopez-Beltran A, Alvarez-Kindelan J, Luque RJ, Blanca A, Quintero A, Montironi R, Cheng L, Gonzalez-Campora R, Requena MJ. Loss of heterozygosity at 9q32–33 (DBC1 locus) in primary non-invasive papillary urothelial neoplasm of low malignant potential and low grade urothelial carcinoma of the bladder and their associated normal urothelium. J Pathol 2008;215:263–272.
Lopez-Beltran A, Blanca A, Montironi R, Cheng L, Regueiro JC. Pleomorphic giant cell carcinoma of the urinary bladder. Hum Pathol 2009;40:1461–1466.
Lopez-Beltran A, Cheng L, Andersson L, et al. Preneoplastic non-papillary lesions and conditions of the urinary bladder. Virchows Arch 2002;440:3–11.
Lopez-Beltran A, Cheng L, Mazzucchelli R, Bianconi M, Blanca A, Scarpelli M, Montironi R. Morphological and molecular profiles and pathways in bladder neoplasms. Anticancer Res 2008;28:2893–2900.
Lopez-Beltran A, Cheng L. Histologic variants of urothelial carcinoma: differential diagnosis and clinical implications. Hum Pathol 2006;37:1371–1388.
Lopez-Beltran A, Cheng L. Stage pT1 bladder carcinoma: diagnostic criteria, pitfalls and prognostic significance. Pathology 2003;35:484–491.
Lopez-Beltran A, Luque RJ, Alvarez-Kindelan J et al. Prognostic factors in survival of patients with stage Ta and T1 bladder urothelial tumors: the role of G1-S modulators (p53, p21Waf1, p27Kip1, cyclin D1, and cyclin D3), proliferation index and clinicopathologic parameters. Am J Clin Pathol 2004;122:444–452.
Lopez-Beltran A, Pacelli A, Rothenberg HJ, et al. Carcinosarcoma and sarcomatoid carcinoma of the bladder: clinicopathologic study of 41 cases. J Urol 1998;159:1497–1503.
Lopez-Beltran A, Pérez-Seoane C, Montironi R, Hernández-Iglesias T, Mackintosh C, de Alava E. Primary primitive neuroectodermal tumour of the urinary bladder: a clinico-pathological study emphasising immunohistochemical, ultrastructural and molecular analyses. J Clin Pathol 2006;59:775–778.
Lopez-Beltran A, Requena MJ, Alvarez-Kindelan J, Quintero A, Blanca A, Montironi R. Squamous differentiation in primary urothelial carcinoma of the urinary tract as seen by MAC387 immunohistochemistry. J Clin Pathol 2007;60:332–325.
Lopez-Beltran A, Requena MJ, Cheng L, Montironi R. Pathological variants of invasive bladder cancer according to their suggested clinical significance. BJU Int 2008;101:275–281.
Lopez-Beltran A, Requena MJ, Montironi R, Blanca A, Cheng L. Plasmacytoid urothelial carcinoma of the bladder. Hum Pathol 2009;40: 1023–1028.
Lopez-Beltran A, Sauter G, Gasser T, et al. Urothelial tumors: infiltrating urothelial carcinoma. In: Eble JN, Sauter G, Epstein JI, Sesterhenn I, eds. World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Urinary System and Male Genital Organs. Lyon: IARC Press, 2004.
Lopez-Beltran A. Bladder cancer: clinical and pathological profile. Scand J Urol Nephrol Suppl 2008;218:95–109.
Lopez-Beltran A, Requena MJ, Montironi R, Blanca A, Cheng L. Plasmacytoid urothelial carcinoma of the bladder. Hum Pathol 2009;40:1023–1028.
Lopez-Beltran A, Cheng L, Prieto R, Blanca A, Montironi R. Lymphoepithelioma-like carcinoma of the prostate. Hum Pathol 2009;40: 982–987.
Lopez-Beltran A, Blanca A, Montironi R, Cheng L, Regueiro JC. Pleomorphic giant cell carcinoma of the urinary bladder. Hum Pathol 2009;40:1461–1466.
Lopez-Beltran A, Amin MB, Oliveira PS, Montironi R, Algaba F, McKenney JK, de Torres I, Mazerolles C, Ruiz JA, Wang M, Cheng L. Urothelial carcinoma of the bladder, lipid cell variant. Clinicopathologic findings and LOH analysis. Am J Surg Pathol 2010;34:371–376.
Lopez-Beltran A, Montironi R, Blanca A, Cheng L. Invasive micropapillary urothelial carcinoma of the bladder. Hum Pathol (in press).
Lopez-Beltran A, Cheng L, Comperat E, Rouprêt M, Blanca A, Menendez CL, Montironi R. Large cell undifferentiated carcinoma of the urinary bladder. Pathology2010;42:364–368.
Lott S, Lopez-Beltran A, Maclennan GT, Montironi R, Cheng L. Soft tissue tumors of the urinary bladder, part I: myofibroblastic proliferations, benign neoplasms, and tumors of uncertain malignant potential. Hum Pathol 2007;38:807–823.
Lott S, Lopez-Beltran A, Montironi R, MacLennan GT, Cheng L. Soft tissue tumors of the urinary bladder Part II: malignant neoplasms. Hum Pathol 2007;38:963–977.
Lott S, Wang M, Zhang S, MacLennan GT, Lopez-Beltran A, Montironi R, Sung MT, Tan PH, Cheng L. Fibroblast growth factor receptor 3 (FGFR3) and TP53 mutation analysis in inverted urothelial papilloma: incidence and etiological considerations. Mod Pathol 2009;22:627–632.
Martin SA, Sears DL, Sebo TJ, et al. Smooth muscle neoplasms of the urinary bladder: a clinicopathologic comparison of leiomyoma and leiomyosarcoma. Am J Surg Pathol 2002;26:292–300.
Mazzucchelli R, Morichetti D, Lopez-Beltran A, Cheng L, Scarpelli M, Kirkali Z, Montironi R. Neuroendocrine tumours of the urinary system and male genital organs: clinical significance. BJU Int 2009;103:286–288.
McKenney JK, Amin MB, Young RH. Urothelial (transitional cell) papilloma of the urinary bladder: a clinicopathologic study of 26 cases. Mod Pathol 2003;16:623–629.
McKenney JK, Desai S, Cohen C, Amin MB. Discriminatory immunohistochemical staining of urothelial carcinoma in situ and non-neoplastic urothelium: an analysis of cytokeratin 20, p53, and CD44 antigens. Am J Surg Pathol 2001;25:1074–1078.
McKenney JK, Gomez JA, Desai S, et al. Morphologic expressions of urothelial carcinoma in situ: a detailed evaluation of its histologic patterns with emphasis on carcinoma in situ with microinvasion. Am J Surg Pathol 2001;25:356–362.
Montironi R, Cheng L, Mazzucchelli R, Scarpelli M, Kirkali Z, Montorsi F, Lopez-Beltran L. Critical evaluation of the prostate from cystoprostatectomies for bladder cancer: Insights from a complete sampling with the whole mount technique. Eur Urol 2009;55:1305–1309.
Montironi R, Lopez-Beltran A, Scarpelli M, Mazzucchelli R, Cheng L. Morphological classification and definition of benign, preneoplastic and non-invasive neoplastic lesions of the urinary bladder. Histopathology 2008;53:621–633.
Montironi R, Lopez-Beltran A, Scarpelli M, Mazzucchelli R, Cheng L. 2004 World Health Organization classification of the noninvasive urothelial neoplasms: Inherent problems and clinical reflections. Eur Urol 2009;8 (Suppl):453–457.
Montironi R, Mazzucchelli R, Scarpelli M, Lopez-Beltran A, Cheng L. Morphological diagnosis of urothelial neoplasms. J Clin Pathol 2008;61:3–10.
Morton MJ, Zhang S, Lopez-Beltran A, MacLennan GT, Eble JN, Montironi R, Sung MT, Tan PH, Zheng S, Zhou H, Cheng L. Telomere shortening and chromosomal abnormalities in intestinal metaplasia of the urinary bladder. Clin Cancer Res 2007;13:6232–6236.
Murphy WM, Takezawa K, Maruniak NA. Interobserver discrepancy using the 1998 World Health Organization/International Society of Urologic Pathology. Classification of urothelial neoplasms: practical choices for patient care. J Urol 2003;168:968–972.
Oliva E, Young RH. Nephrogenic adenoma of the urinary tract: a review of the microscopic appearance of 80 cases with emphasis on unusual features. Mod Pathol 1995;8:722–730.
Oosterhuis JW, Schapers RF, Janssen-Heijnen ML, et al. Histological grading of papillary urothelial carcinoma of the bladder: prognostic value of the 1998 WHO/ISUP classification system and comparison with conventional grading systems. J Clin Pathol 2002;55:900–905.
Pan C, Yang XJ, Lopez-Beltran A, et al. C-kit expression in small cell carcinoma of the urinary bladder: prognostic and therapeutic implications. Mod Pathol 2005;18:320–323.
Pan CC, Yu IT, Yang AH, et al. Clear cell myomelanocytic tumor of the urinary bladder. Am J Surg Pathol 2003;27:689–692.
Pant-Purohit M, Lopez-Beltran A, Montironi R, MacLennan GT, Cheng L. Small cell carcinoma of the urinary bladder. Histol Histopathol 2010;25:217–221.
Parker DC, Folpe AL, Bell J, et al. Potential utility of uroplakin III, thrombomodulin, high molecular weight cytokeratin, and cytokeratin 20 in noninvasive, invasive, and metastatic urothelial (transitional cell) carcinomas. Am J Surg Pathol 2003;27:1–10.
Paterson RF, Ulbright TM, MacLennan GT, et al. Molecular genetic alterations in the laser-capture microdissected stroma adjacent to bladder carcinoma. Cancer 2003;98:1830–1836.
Samaratunga H, Khoo K. Micropapillary. Variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study. Histopathology 2004;45:55–64.
Skinnider BF, Oliva E, Young RH, et al. Expression of alpha-methylacyl-CoA racemase (P504S) in nephrogenic adenoma: a significant immunohistochemical pitfall compounding the differential diagnosis with prostatic adenocarcinoma. Am J Surg Pathol 2004;28:701–705.
Sung MT, Eble JN, Wang M, Tan PH, Lopez-Beltran A, Cheng L. Inverted papilloma of the urinary bladder: a molecular genetic appraisal. Mod Pathol 2006;19:1289–1294.
Sung MT, Lopez-Beltran A, Eble JN, MacLennan GT, Tan PH, Montironi R, Jones TD, Ulbright TM, Blair JE, Cheng L. Divergent pathway of intestinal metaplasia and cystitis glandularis of the urinary bladder. Mod Pathol 2006;19:1395–1401.
Sung MT, Maclennan GT, Lopez-Beltran A, Montironi R, Cheng L. Natural history of urothelial inverted papilloma. Cancer 2006;107:2622–2627.
Sung MT, Wang M, MacLennan GT, Eble JN, Tan PH, Lopez-Beltran A, Montironi R, Harris JJ, Kuhar M, Cheng L. Histogenesis of sarcomatoid urothelial carcinoma of the urinary bladder: evidence for a common clonal origin with divergent differentiation. J Pathol 2007;211:420–430.
Sung MT, Zhang S, MacLennan GT, Lopez-Beltran A, Montironi R, Wang M, Tan PH, Cheng L. Histogenesis of clear cell adenocarcinoma in the urinary tract: evidence of urothelial origin. Clin Cancer Res 2008;14:1947–1955.
Sung MT, Zhang S, Lopez-Beltran A, Montironi R, Wang M, Davidson DD, Koch MO, Cain MP, Rink RC, Cheng L. Urothelial carcinoma following augmentation cystoplasty: An aggressive variant with distinct clinicopathological characteristics and molecular genetic alterations. Histopathology 2009;55:161–173.
Taylor DC, Bhagavan BS, Larsen MP, et al. Papillary urothelial hyperplasia: a precursor to papillary neoplasm. Am J Surg Pathol 1996;20:1481–1488.
Volmar KE, Chan TY, De Marzo AM, et al. Nests mimicking urothelial carcinoma: a morphologic and immunohistochemical comparison to the nested variant of urothelial carcinoma. Am J Surg Pathol 2003;27:1243–1252.
Wang HL, Lu DW, Yerian LM, et al. Immunohistochemical distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma. Am J Surg Pathol 2001;25:1380–1387.
Wang X, MacLennan GT, Lopez-Beltran A, Cheng L. Small cell carcinoma of the urinary bladder – histogenesis, genetics, diagnosis, biomarkers, treatment, and prognosis. Appl Immunohistochem Mol Morphol 2007;15:8–18.
Wang X, MacLennan GT, Zhang S, Montironi R, Lopez-Beltran A, Tan PH, Foster S, Baldridge LA, Cheng L. Sarcomatoid carcinoma of the upper urinary tract: Clinical outcome and molecular characterization. Hum Pathol2009;40:211–217.
Yorukoglu K, Tuna B, Dikicioglu E, et al. Reproducibility of the 1998 World Health Organization/International Society of Urologic Pathology classification of papillary urothelial neoplasms of the urinary bladder. Virchows Arch 2003;443:734–740.
Young RH, Bostwick DG. Florid cystitis glandularis with mucin extravasation: a mimic of adenocarcinoma. Am J Surg Pathol 1996;20:1462–1468.
Young RH, Clement PB. Mullerianosis of the urinary bladder. Mod Pathol 1996;9:731–737.
Young RH, Oliva E. Invasive transitional cell carcinomas of the urinary bladder that may be under diagnosed: a report of four cases exemplifying the homology between neoplastic and nonneoplastic transitional cell lesions. Am J Surg Pathol 1996;20:1448–1454.
Young RH, Zukerberg LR. Microcystic transitional cell carcinoma of the urinary bladder: a report of four cases. Am J Clin Pathol 1991;96:635–639.
Young RH. Pseudoneoplastic lesions of the urinary bladder and urethra: a selective review with emphasis on recent information. Semin Diagn Pathol 1997;14:133–146.
Young RH. Tumor-like lesions of the urinary bladder. Mod Pathol 2009;22 (S2):S37–52.
Zhou M, Epstein JI, Young RH. Paraganglioma of the urinary bladder: a lesion that may be misdiagnosed as urothelial carcinoma in transurethral resection specimens. Am J Surg Pathol 2004;28:94–100.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Cheng, L., Lopez-Beltran, A., Bostwick, D.G. (2011). Urinary Bladder. In: Cheng, L., Bostwick, D. (eds) Essentials of Anatomic Pathology. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-6043-6_36
Download citation
DOI: https://doi.org/10.1007/978-1-4419-6043-6_36
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-6042-9
Online ISBN: 978-1-4419-6043-6
eBook Packages: MedicineMedicine (R0)